You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Diatrizoate Meglumine, and what generic alternatives are available?

Diatrizoate Meglumine is a drug marketed by Bracco, Anda Repository, and Annora Pharma. and is included in three NDAs.

The generic ingredient in DIATRIZOATE MEGLUMINE is diatrizoate meglumine; diatrizoate sodium. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the diatrizoate meglumine; diatrizoate sodium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DIATRIZOATE MEGLUMINE?
  • What are the global sales for DIATRIZOATE MEGLUMINE?
  • What is Average Wholesale Price for DIATRIZOATE MEGLUMINE?
Drug patent expirations by year for DIATRIZOATE MEGLUMINE
Recent Clinical Trials for DIATRIZOATE MEGLUMINE

Identify potential brand extensions & 505(b)(2) entrants

Lawson Health Research InstitutePhase 4

See all DIATRIZOATE MEGLUMINE clinical trials

Medical Subject Heading (MeSH) Categories for DIATRIZOATE MEGLUMINE

US Patents and Regulatory Information for DIATRIZOATE MEGLUMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco DIATRIZOATE MEGLUMINE diatrizoate meglumine INJECTABLE;INJECTION 010040-017 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Anda Repository DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM diatrizoate meglumine; diatrizoate sodium SOLUTION;ORAL, RECTAL 214201-001 Jun 27, 2022 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Annora Pharma DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM diatrizoate meglumine; diatrizoate sodium SOLUTION;ORAL, RECTAL 215049-001 Nov 17, 2023 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.